Neuroblastoma in 1993

1992 Berthold, 1992, Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma, Eur J Cancer, 28A, 1950, 10.1016/0959-8049(92)90234-S Bourrhis, 1991, Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma, Cancer Res, 51, 33 Bourrhis, 1991, N-myc genomic content and DNA ploidy in stage IVS neuroblastoma, J Clin Oncol, 9, 1371, 10.1200/JCO.1991.9.8.1371 Bowman, 1991, Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St. Jude Children's Research Hospital experience, 1962 to 1988, J Clin Oncol, 9, 1599, 10.1200/JCO.1991.9.9.1599 Brodeur, 1993, Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment, J Clin Oncol, 10.1200/JCO.1993.11.8.1466 Brodeur, 1988, International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma, J Clin Oncol, 6, 1874, 10.1200/JCO.1988.6.12.1874 Brodeur, 1984, Amplification of N-myc in untreated humanneuroblastomas correlates with advanced disease stage, Science, 224, 1121, 10.1126/science.6719137 Chan, 1991, P-glycoprotein expression asa predictor of the outcome of therapy for neuroblastoma, NEJ Med, 325, 1608, 10.1056/NEJM199112053252304 Cheung, 1991, Chemotherapy dose intensity correlates strongly with response, median survival, and median progression free survival inmetastatic neuroblastoma, J Clin Oncol, 9, 1050, 10.1200/JCO.1991.9.6.1050 Cohn, 1987, N-myc amplification in an infant with stage IVS neuroblastoma, J Clin Oncol, 5, 1441, 10.1200/JCO.1987.5.9.1441 Corbett, 1992, Pilot study of high dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma, Eur J Cancer, 28A, 1324, 10.1016/0959-8049(92)90509-Z Craft, 1992, A pilot study of screening for neuroblastoma in the North of England, Am J Ped Hematol/Onc, 14, 337, 10.1097/00043426-199211000-00010 Fong, 1992, Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas, Cancer Res, 52, 1780 Gordon, 1992, Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma, Eur J Cancer, 28A, 1319, 10.1016/0959-8049(92)90508-Y Haase, 1989, Improvement in survival after excision, of primary tumor in stage III neuroblastoma, J Ped Surg, 24, 194, 10.1016/S0022-3468(89)80248-9 Hayashi, 1992, Biology of neuroblastomas in Japan found by screening, Am J Ped Hematol/Onc, 14, 342, 10.1097/00043426-199211000-00011 Ladisch, 1985, Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma, Lancet, 136, 10.1016/S0140-6736(85)91906-3 Lok, 1984, Cellular DNA content as a preditor of response to chemotherapy in infants with unresectable neuroblastoma, NEJ Med., 311, 231, 10.1056/NEJM198407263110405 Nakagawara, 1990, N-myc oncogene and stage IVS neuroblastoma, Cancer, 65, 1960, 10.1002/1097-0142(19900501)65:9<1960::AID-CNCR2820650914>3.0.CO;2-4 Negrier, 1991, Interleukin-2 and lymphokine activated killer cells in 15 children with advanced metastatic neuroblastoma, J Clin Oncol, 9, 1363, 10.1200/JCO.1991.9.8.1363 Philip, 1991, Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?, J Clin Oncol, 9, 1037, 10.1200/JCO.1991.9.6.1037 Sawada, 1992, Past and future of neuroblastoma screening in Japan, Am J Ped Hematol/Onc, 14, 320, 10.1097/00043426-199211000-00007 Shimada, 1984, Histopathologic prognostic factors in neuroblastic tumours: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas, JNCI, 73, 405, 10.1093/jnci/73.2.405 Stiller, 1992, International variations in the incidence of neuroblastoma, Int J Cancer, 53, 538, 10.1002/ijc.2910520407 Tanaka, 1988, Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with patient's prognosis, Cancer Res, 48, 1030 Wilson, 1991, Neuroblastoma stage IVS: a heterogeneous disease, Med Ped Oncol, 19, 467, 10.1002/mpo.2950190604 Zeltzer, 1986, Serum neuron-specific enolase in children with neuroblastoma, Cancer, 57, 1230, 10.1002/1097-0142(19860315)57:6<1230::AID-CNCR2820570628>3.0.CO;2-#